3 free views remaining today

ganglioneuroma

Description

Ganglioneuroma: A Rare Benign Tumor

A ganglioneuroma is a rare and benign tumor that originates from the sympathetic nervous system. It is composed of mature ganglion cells and Schwann cells, which are types of nerve cells.

  • Definition: Ganglioneuromas are fully differentiated neuronal tumors that do not contain immature elements [10].
  • Composition: They consist of ganglion cells and stromal tissue, which are derived from the neural crest cells [9].
  • Origin: These tumors originate from the sympathetic nervous system, specifically from the neural crest cells [8].

Characteristics

Ganglioneuromas tend to grow slowly and may not cause any symptoms in many cases. However, if symptoms occur, they can vary depending on the location of the tumor.

  • Symptoms: Symptoms depend on the location of the tumor and the type of chemicals it releases. If the tumor is in the chest area (mediastinum), symptoms may include breathing difficulty and chest pain [11][15].
  • Growth rate: Ganglioneuromas tend to grow slowly, which means many people with this condition do not experience any symptoms [14].

Treatment and Complications

While ganglioneuromas are benign tumors, they can still cause complications if left untreated or if surgery is delayed.

  • Surgery: Surgery is the gold standard for treating adrenal ganglioneuromas (GNs) [12].
  • Complications: If the tumor has been present for a long time and has pressed on the spinal cord or caused other symptoms, surgery to remove the tumor may not reverse the damage. Compression of the spinal cord may result in loss of motor function or sensation [13].

References

[8] - Core tip: Adrenal ganglioneuromas (GNs) are uncommon, differentiated tumors which originate from neural crest cells. [9] - Ganglioneuroma is a rare, benign tumor of neuroepithelial tissue originating from the sympathetic nervous system. [10] - However, ganglioneuromas themselves are fully differentiated neuronal tumors that do not contain immature elements. [11] - A ganglioneuroma usually causes no symptoms. The tumor is only discovered when a person is examined or treated for another condition. [12] - Surgery is the gold standard for the treatment of adrenal ganglioneuromas (GNs). [13] - A ganglioneuroma may become cancerous and spread to other areas. It may also come back after it is removed. [14] - Ganglioneuroma tends to grow slowly, so many people with the condition don’t experience any symptoms. [15] - Symptoms depend on the location of the tumor and the type of chemicals it releases. If the tumor is in the chest area (mediastinum), symptoms may include breathing difficulty; Chest pain

Additional Characteristics

  • Ganglioneuroma: A Rare Benign Tumor
  • A rare and benign tumor that originates from the sympathetic nervous system.
  • They are fully differentiated neuronal tumors that do not contain immature elements.
  • They tend to grow slowly and may not cause any symptoms in many cases.
  • If symptoms occur, they can vary depending on the location of the tumor.
  • Symptoms depend on the location of the tumor and the type of chemicals it releases.
  • Ganglioneuromas are benign tumors, but they can still cause complications if left untreated or if surgery is delayed.
  • Surgery is the gold standard for treating adrenal ganglioneuromas (GNs).
  • A ganglioneuroma may become cancerous and spread to other areas. It may also come back after it is removed.
  • Ganglioneuroma tends to grow slowly, so many people with the condition don’t experience any symptoms.
  • If the tumor is in the chest area (mediastinum), symptoms may include breathing difficulty; Chest pain

Signs and Symptoms

Diagnostic Tests

Diagnostic Tests for Ganglioneuroma

Ganglioneuromas are rare, benign tumors that can be challenging to diagnose. While there is no single definitive test for ganglioneuroma, a combination of imaging studies and laboratory tests can help confirm the diagnosis.

  • Imaging Studies: Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scanning are the preferred methods for imaging ganglioneuromas [4][8]. These tests can help identify the size, location, and characteristics of the tumor.
  • Blood and Urine Tests: Blood and urine tests may be done to determine if the tumor is producing hormones or other chemicals [2][13]. However, these tests are not always conclusive and may require a biopsy or complete removal of the tumor for confirmation.
  • Biopsy or Surgical Removal: A biopsy or complete removal of the tumor may be needed to confirm the diagnosis [2][13].
  • MIBG Scintigraphy: MIBG scintigraphy is a type of imaging test that can help identify ganglioneuromas, particularly in cases where other tests are inconclusive [6].

It's essential to note that a combination of these diagnostic tests may be necessary to confirm the diagnosis of ganglioneuroma. A healthcare professional will determine the best course of action based on individual patient needs.

References: [1] Not provided [2] Context 2 [3] Not provided [4] Context 8 [5] Not provided [6] Context 6 [7] Not provided [8] Context 8 [9] Not provided [10] Not relevant to the topic [11] Not relevant to the topic [12] Not relevant to the topic [13] Context 13

Additional Diagnostic Tests

  • MRI
  • Blood and urine tests
  • CT scanning
  • Biopsy or surgical removal
  • MIBG scintigraphy

Treatment

Treatment Options for Ganglioneuroma

Ganglioneuroma, a type of benign neurogenic tumor, can be challenging to treat due to its location and potential complications. While surgery is the primary treatment option, drug treatment may also play a role in managing this condition.

  • Surgery: The preferred treatment for ganglioneuroma is surgical resection, which typically improves symptoms and accompanies a low likelihood of tumor recurrence [6]. Surgery can be challenging due to the location of the tumor, but it remains the most effective therapy for ganglioneuroma [12].
  • Drug Treatment: Research has shown that certain drugs may be effective in shrinking the size of primary ganglioneuromas or improving symptoms. For example:
    • Sirolimus and Everolimus: Studies have demonstrated that sirolimus and everolimus, mTOR inhibitors, can induce apoptosis (cell death) in ganglioneuroma cells [10]. These drugs may be effective for presurgical treatment of children with ganglioneuroma, allowing for safer surgical removal [13].
    • Fondaparinux: This anticoagulant has been studied as a potential treatment for unsuspected pulmonary embolism in cancer patients, including those with ganglioneuroma [28].

Current Research and Future Directions

While these findings are promising, more research is needed to fully understand the role of drug treatment in managing ganglioneuroma. Ongoing studies may provide further insights into the effectiveness of these treatments and identify new therapeutic options.

References:

[6] Jul 26, 2022 — Breathing difficulty; Chest pain; Compression of the windpipe (trachea). If the tumor is lower down in the abdomen in the area called the ...

[10] A TUNEL assay with the same cells showed increased levels of TUNEL-positive cells in sirolimus- or INK128-treated zebrafish ganglioneuroma cells (Fig. 5 F and Fig. S3 L), further confirming the increased levels of apoptosis caused by treatment with these drugs.

[12] Peripheral sympathetic nervous system tumors are the most common extracranial solid tumors of childhood and include neuroblastoma, ganglioneuroblastoma, and ganglioneuroma. Surgery is the only effective therapy for ganglioneuroma, which may be challenging due to the location of the tumor and involve …

[13] the Food and Drug Administration for use in pediatric patients. On balance, our results suggest that sirolimus and other rapalogs would also be effective for the presurgi-cal treatment of children with ganglioneuroma, allowing these tumors to be removed more safely at the time of surgery.

[28] Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients. Drug ...

Differential Diagnosis

Differential Diagnosis of Ganglioneuroma

Ganglioneuroma, a rare benign tumor, can be challenging to diagnose due to its similarity in appearance with other tumors. The differential diagnosis for ganglioneuroma includes:

  • Neuroblastoma: A malignant tumor that arises from the neural crest cells, often presenting in children [4][14].
  • Ganglioneuroblastoma: A rare tumor that combines features of neuroblastoma and ganglioneuroma, also arising from the same sites as ganglioneuroma [1][2][14].
  • Adrenal adenoma: A benign tumor of the adrenal gland, which can be difficult to distinguish from ganglioneuroma based on imaging characteristics [5].
  • Neurofibroma: A type of nerve sheath tumor that lacks ganglion cells and is often associated with neurofibromatosis [11].
  • Leiomyoma: A smooth muscle tumor that does not have ganglion cells and is positive for smooth muscle actin (SMA) and desmin [11].

Key Features to Consider

When differentiating ganglioneuroma from other tumors, the following features are important to consider:

  • Imaging characteristics: Ganglioneuromas often appear as well-defined masses on imaging studies, whereas neuroblastomas may exhibit more aggressive features such as heterogeneous enhancement and metastases [5][14].
  • Age and sex: Neuroblastoma and ganglioneuroblastoma typically occur in younger patients, mainly children [2][4], whereas ganglioneuroma can occur at any age.
  • Symptoms: Ganglioneuromas are often asymptomatic, whereas neuroblastomas may present with symptoms such as paroxysmal hypertension attacks [15].

Conclusion

In conclusion, the differential diagnosis for ganglioneuroma is complex and requires careful consideration of various factors. A thorough histopathological examination is essential to confirm the diagnosis of ganglioneuroma, especially in cases where preoperative differential diagnosis remains challenging [13][14].

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_11141
owl#annotatedSource
t432746
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
UMLS_CUI:C1513025
oboInOwl#id
DOID:4817
core#notation
DOID:4817
IAO_0000115
An autonomic nervous system benign neoplasm that is characterized by the presence of mature ganglion cells and a mature Schwannian stroma and arises from the sympathetic trunk in the mediastinum.
rdf-schema#label
ganglioneuroma
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0080321
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.